What Researchers Did
Researchers evaluated the impact of adding hyperbaric oxygen (HBO) therapy to standard surgical and antibiotic treatment for necrotizing fasciitis on patient mortality and the number of debridements needed.
What They Found
Patients receiving HBO therapy had significantly lower mortality (23%) compared to those without HBO (66%). Additionally, HBO-treated patients required fewer debridements to achieve wound control, averaging 1.2 debridements per patient versus 3.3 for the non-HBO group.
What This Means for Canadian Patients
For Canadian patients diagnosed with necrotizing fasciitis, incorporating hyperbaric oxygen therapy alongside surgery and antibiotics could potentially improve survival rates and reduce the number of surgical procedures required. This approach may lead to better patient outcomes and a less invasive treatment course.
Canadian Relevance
This study has no direct Canadian connection as it was conducted in the United States.
Study Limitations
The study's retrospective nature and potential baseline differences in patient severity between groups are notable limitations.